Citation: | HE Cuixia, ZHU Minhui, XU Yuanyuan, WANG Xuefeng, DING Jiaxiang, ZHOU Huan. Role of the transmembrane protein TMEM88 in acute liver injury induced by LPS/D-GaIN[J]. Chinese Journal of General Practice, 2024, 22(5): 786-790. doi: 10.16766/j.cnki.issn.1674-4152.003503 |
[1] |
高娟, 伍燕, 郑之峻, 等. 黄芩苷对脂多糖诱导人牙龈成纤维细胞表达炎症因子的影响[J]. 中华全科医学, 2022, 20(12): 2002-2005. doi: 10.16766/j.cnki.issn.1674-4152.002755
GAN J, WU Y, ZHENG Z J, et al. Effect of baicalin on the expression of inflammatory factors in human gingival fibroblasts induced by lipopolysaccharide[J]. Chinese Journal of General Practice, 2022, 20(12): 2002-2005. doi: 10.16766/j.cnki.issn.1674-4152.002755
|
[2] |
蔡艳, 糜大国, 蒋伟, 等. 苦参素对脂多糖诱导的海马神经元凋亡的保护作用[J]. 中华全科医学, 2020, 18(10): 1660-1662, 1765. doi: 10.16766/j.cnki.issn.1674-4152.001586
CAI Y, MI D G, JIANG W, et al. Protective effect of matrine on hippocampal neuron apoptosis induced by lipopolysaccharide[J]. Chinese Journal of General Practice, 2020, 18(10): 1660-1662, 1765. doi: 10.16766/j.cnki.issn.1674-4152.001586
|
[3] |
ZHOU H, ZHU X Y, YAO Y, et al. TMEM88 modulates lipid synthesis and metabolism cytokine by regulating Wnt/β-catenin signaling pathway in non-alcoholic fatty liver disease[J]. Front Pharmacol, 2021, 12: 798735. DOI: 10.3389/fphar.2021.798735.
|
[4] |
ZHANG X, WAN J X, KE Z P, et al. TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma[J]. Tumour Biol, 2017, 39(7): 1010428317708900. DOI: 10.1177/1010428317708900.
|
[5] |
LI M, SONG K, HUANG X W, et al. GDF-15 prevents LPS and D-galactosamine-induced inflammation and acute liver injury in mice[J]. Int J Mol Med, 2018, 42(3): 1756-1764.
|
[6] |
龚红霞, 曾元丁, 苏韫, 等. 大补脾汤联合奥沙利铂对胃癌荷瘤小鼠瘤组织TLR4/MyD88/NF-κB信号通路及下游相关分子的影响[J]. 中国免疫学杂志, 2023, 39(3): 572-577. doi: 10.3969/j.issn.1000-484X.2023.03.021
GONG H X, ZENG Y D, SU Y, et al. Effects of Da Bupi Decoction combined with oxaliplatin on TLR4/MyD88/NF-κB signaling pathway and downstream related molecules in gastric cancer bearing mice[J]. Chinese Journal of Immunology, 2023, 39(3): 572-577. doi: 10.3969/j.issn.1000-484X.2023.03.021
|
[7] |
邵长春. 脂多糖在肝再生及其促进肝癌发生中的作用机制研究[D]. 上海: 中国人民解放军海军军医大学, 2021.
SHAO C C. Study on the mechanism of lipopolysaccharide in liver regeneration and its promotion of hepatocellular carcinoma[D]. Shanghai: Naval Medical University, 2021.
|
[8] |
张一凡. TFF3改善NASH肝损伤的机制及降脂颗粒的调控作用[D]. 上海: 上海中医药大学, 2019.
ZHANG Y F. Mechanism of TFF3 ameliorating liver injury in NASH and regulation of Jiangzhi granules[D]. Shanghai: Shanghai University of Traditional Chinese Medicine, 2019.
|
[9] |
XU S, ZHAO M, WANG Q J, et al. Effectiveness of probiotics and prebiotics against acute liver injury: a meta-analysis[J]. Front Med, 2021, 8: 739337. DOI: 10.3389/fmed.2021.739337.
|
[10] |
MEZZANO G, JUANOLA A, CARDENAS A, et al. Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis[J]. Gut, 2022, 71(1): 148-155. doi: 10.1136/gutjnl-2020-322161
|
[11] |
GE Y X, WANG C H, HU F Y, et al. New advances of TMEM88 in cancer initiation and progression, with special emphasis on Wnt signaling pathway[J]. J Cell Physiol, 2018, 233(1): 79-87. doi: 10.1002/jcp.25853
|
[12] |
ZHANG S H, DAI H T, LI W Y, et al. TMEM116 is required for lung cancer cell motility and metastasis through PDK1 signaling pathway[J]. Cell Death Dis, 2021, 12(12): 1086. doi: 10.1038/s41419-021-04369-1
|
[13] |
RAO J W, WU X K, ZHOU X Z, et al. TMEM205 is an independent prognostic factor and is associated with immune cell infiltrates in hepatocellular carcinoma[J]. Front Genet, 2020, 11: 575776. DOI: 10.3389/fgene.2020.575776.
|
[14] |
ZHAO X, LI G, CHONG T, et al. TMEM88 exhibits an antiproliferative and anti-invasive effect in bladder cancer by downregulating Wnt/β-catenin signaling[J]. J Biochem Mol Toxicol, 2021, 35(8): e22835. DOI: 10.1002/jbt.22835.
|
[15] |
GENG Q Q, CHEN X, CHEN N Z. Transmembrane protein 88 exerts a tumor-inhibitory role in thyroid cancer through restriction of Wnt/β-catenin signaling[J]. Exp Cell Res, 2020, 395(2): 112193. DOI: 10.1016/j.yexcr.2020.112193.
|
[16] |
CAI M, NI W J, WANG Y H, et al. Targeting TMEM88 as an attractive therapeutic strategy in malignant tumors[J]. Front Oncol, 2022, 12: 906372. DOI: 10.3389/fonc.2022.906372.
|
[17] |
XU T, PAN L X, GE Y X, et al. TMEM88 mediates inflammatory cytokines secretion by regulating JNK/P38 and canonical Wnt/β-catenin signaling pathway in LX-2 cells[J]. Inflammopharmacology, 2018, 26(5): 1339-1348. doi: 10.1007/s10787-017-0419-z
|
[18] |
LI L Y, YANG C C, LI S W, et al. TMEM88 modulates the secretion of inflammatory factors by regulating YAP signaling pathway in alcoholic liver disease[J]. Inflamm Res, 2020, 69(8): 789-800. doi: 10.1007/s00011-020-01360-y
|
[19] |
LEE H, EVANS T. TMEM88 inhibits Wnt signaling by promoting Wnt signalosome localization to multivesicular bodies[J]. iScience, 2019, 19: 267-280. doi: 10.1016/j.isci.2019.07.039
|
[20] |
SUN Z M, NING Q, LI H, et al. Transmembrane protein 88 inhibits transforming growth factor-β1-induced-extracellular matrix accumulation and epithelial-mesenchymal transition program in human pleural mesothelial cells through modulating TGF-β1/Smad pathway[J]. J Recept Signal Transduct Res, 2022, 42(1): 60-66. doi: 10.1080/10799893.2020.1843493
|
[21] |
XU T, PAN L X, LI L Y, et al. MicroRNA-708 modulates hepatic stellate cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88[J]. J Cell Mol Med, 2020, 24(13): 7127-7140. doi: 10.1111/jcmm.15119
|